Analytical Standardization of Ajitadi Agad: A Classical Polyherbal Antidote in Light of Contemporary Parameters

Background: Agada Tantra, one of the eight specialties of Ayurveda, emphasizes management of poisoning through polyherbal formulations known as Agada. Ajitagada, is described in Ashtanga Sangraha Uttarasthana (40/101) as a classical formulation indicated in the treatment of Sthavara (plant/mineral-origin) and Jangama (animal-origin) poisons. It contains Vidanga (Embelia ribes), Patha (Cissampelos pareira), Triphala (Amalaki, Haritaki, Bibhitaki), Ajmoda (Carum roxburghianum), Hingu (Ferula asafoetida), Chitraka (Plumbago zeylanica), Tagara (Valeriana wallichii), Sunthi (Zingiber officinale), Maricha (Piper nigrum), Pippali (Piper longum), and salts (Lavana Varga). Objective: To evaluate Ajitagada using modern analytical parameters, including pharmacognostical, physicochemical, and organoleptic evaluation, in order to establish quality standards and scientific validation for global acceptance. Materials and Methods: Ajitagada churna was prepared as per classical guidelines of Sharangadhara Samhita. Raw materials were authenticated through macroscopic and microscopic methods, and processed individually before formulation. Analytical studies included organoleptic evaluation, physicochemical constants (pH, loss on drying, ash values, water-soluble and alcohol-soluble extractives). Results: Ajitagada exhibited characteristic organoleptic features such as brownish appearance, pungent odor, and astringent-pungent taste. Physicochemical analysis confirmed acceptable quality parameters: moisture content within permissible limits, ash values indicative of mineral content, and satisfactory extractive values. Preliminary phytochemical screening revealed the presence of alkaloids, tannins, glycosides, flavonoids, and saponins, aligning with the formulation’s traditional Vishaghna (anti-toxic) claims. Conclusion: The analytical evaluation of Ajitadagada provides preliminary validation for its identity, purity, and quality. These findings strengthen its classical claims as an antidotal formulation and establish a baseline for future pharmacological and clinical investigations.